DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Bicycle Therapeutics Q4 EPS $(0.25) Beats $(0.52) Estimate, Sales $5.281M Does Not Compare To $1.85M Estimate

Bicycle Therapeutics (NASDAQ:BCYC) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.52) by 51.92 percent. The company reported quarterly sales of $5.281 million which beat

Benzinga · 03/10/2020 11:00

Bicycle Therapeutics (NASDAQ:BCYC) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.52) by 51.92 percent. The company reported quarterly sales of $5.281 million which beat the analyst consensus estimate of $1.85 million by 185.46 percent.